MCI-186 in open label phase

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01492686 (ClinicalTrials.gov)	December 2011	11/12/2011	Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis	Efficacy and Safety Study of MCI-186for Treatment of the Patients With Amyotrophic Lateral Sclerosis ...	Amyotrophic Lateral Sclerosis (ALS)	Drug: MCI-186;Drug: Placebo;Drug: MCI-186 in open label phase	Mitsubishi Tanabe Pharma Corporation	NULL	Completed	20 Years	75 Years	All	137	Phase 3	Japan

First Previous1Next Last